Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

298
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
298
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

422
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
422
Improving Translational Accuracy02:07

Improving Translational Accuracy

10.2K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Artificial Intelligence-Driven Multimorbidity Framework Reveals a Shared Metabolic and Immune Core Across Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Biomedicines·2026
Same author

Education, Sex, and Age Shape Rey Complex Figure Performance in Cognitively Normal Adults: An Interpretable Machine Learning Study.

Journal of clinical medicine·2025
Same author

ReduXis: A Comprehensive Framework for Robust Event-Based Modeling and Profiling of High-Dimensional Biomedical Data.

International journal of molecular sciences·2025
Same author

Comprehensive Anatomical Staging Predicts Clinical Progression in Mild Cognitive Impairment: A Data-Driven Approach.

International journal of molecular sciences·2025
Same author

TrialSieve: A Comprehensive Biomedical Information Extraction Framework for PICO, Meta-Analysis, and Drug Repurposing.

Bioengineering (Basel, Switzerland)·2025
Same author

Stratifying risk of Alzheimer's disease in healthy middle-aged individuals with machine learning.

Brain communications·2025
Same journal

EHR Sampling Interval Bias Detection and Burden of Blood Pressure Excursions: Implications for Clinical Decision Support and Model Validity in Pediatric ECMO.

Information (Basel)·2026
Same journal

AI-Based Detection of Optical Microscopic Images of <i>Pseudomonas aeruginosa</i> in Planktonic and Biofilm States.

Information (Basel)·2026
Same journal

Multi-Modal Fusion of Routine Care Electronic Health Records (EHR): A Scoping Review.

Information (Basel)·2025
Same journal

Effect of Elevated Temperature on Physical Activity and Falls in Low-Income Older Adults Using Zero-Inflated Poisson and Graphical Models.

Information (Basel)·2025
Same journal

Multimodal Brain Growth Patterns: Insights from Canonical Correlation Analysis and Deep Canonical Correlation Analysis with Auto-Encoder.

Information (Basel)·2025
Same journal

Availability of Physical Activity Tracking Data from Wearable Devices for Glaucoma Patients.

Information (Basel)·2023
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

548

Data Augmentation with Cross-Modal Variational Autoencoders (DACMVA) for Cancer Survival Prediction.

Sara Rajaram1, Cassie S Mitchell1,2

  • 1Laboratory for Pathology Dynamics, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.

Information (Basel)
|April 26, 2024
PubMed
Summary
This summary is machine-generated.

DACMVA enhances deep learning for predictive medicine by augmenting cross-modal data and imputing missing values. This novel framework improves cancer survival prediction, even with limited or missing gene expression data.

Keywords:
Generative Adversarial NetworkVariational Autoencodercancer survival predictiondata augmentation

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

259
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Related Experiment Videos

Last Updated: Jun 27, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

548
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

259
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Area of Science:

  • Artificial Intelligence
  • Bioinformatics
  • Computational Biology

Background:

  • Deep Learning (DL) models require robust data augmentation for predictive medicine.
  • Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs) are crucial for cross-modal data translation.
  • Handling missing data in tabular datasets is a significant challenge for DL.

Purpose of the Study:

  • To introduce DACMVA, a novel framework for data augmentation in cross-modal datasets.
  • To improve DL performance in predictive tasks, particularly with missing data.
  • To enhance cancer survival prediction using tabular gene expression data.

Main Methods:

  • DACMVA framework utilizes cross-modal loss for improved imputation quality.
  • Employs training strategies for regularized latent spaces inspired by Autoencoder latent space alignment.
  • Integrates oversampling of augmented data into prediction training.

Main Results:

  • DACMVA significantly improved cancer survival prediction accuracy (p << 0.001).
  • Outperformed non-augmented baselines and existing augmentation methods across various missing data percentages (4%, 90%, 95%).
  • Demonstrated effectiveness in low-data regimes and tabular data with continuous labels.

Conclusions:

  • DACMVA offers a powerful solution for data augmentation and missing data imputation in DL for predictive medicine.
  • The framework shows substantial performance gains, especially in challenging scenarios with limited or missing data.
  • DACMVA advances the state-of-the-art in applying DL to complex biological datasets for improved patient outcome prediction.